<DOC>
	<DOCNO>NCT00545844</DOCNO>
	<brief_summary>Effectiveness add montelukast inhaled corticosteroid adult subject uncontrolled asthma allergic rhinitis .</brief_summary>
	<brief_title>Singulair ( R ) In Asthma And Allergic Rhinitis ( 0476-383 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient user Inhaled Corticosteroid ( ICS ) ICS/LongActing Beta 2Agonist ( ICS/LABA ) dosage Peak expiratory flow &gt; = 80 % predicted value day visit 1 Uncontrolled per Canadian asthma consensus guideline Unwilling stop regular use histamine H1 antagonists allergic rhinitis symptom Unwilling stop use antihistamine eye drop cromoglycate eye drop ophthalmic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>